Skip to main content
Premium Trial:

Request an Annual Quote

S2 Genomics, Riken Partner on Single-Cell Genomics Applications

NEW YORK – S2 Genomics said on Tuesday that Japan's RIKEN Center for Integrated Medical Sciences will evaluate and further develop single-cell sequencing applications on the S2 Genomics' Singulator tissue prep system under and early-access program.  

According to Livermore, California-based S2 Genomics, the Singulator platform combines enzymatic and mechanical disruption to produce suspensions of cells or nuclei for downstream single-cell applications.

S2 Genomics plans to commercially launch the platform later this year as a research-use-only instrument.

"The Singulator automates and standardizes the dissociation of solid tissues and can improve the quality of single-cell and single-nuclei data from a variety of solid tissue types," S2 Genomics CEO and President Stevan Jovanovich said in a statement. "We are excited to work with the RIKEN IMS to evaluate the performance of the system and to develop new applications for the Singulator platform."

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.